Tesla Speeds Ahead, While Teva Hits the Skids

On this Market Foolery podcast, host Chris Hill and Motley Fool One's Bill Mann discuss two very different companies with two wildly different places in the market today.

As electric-car innovator Tesla (NASDAQ: TSLA) begins to deliver its long-awaited Model 3, the Fools discuss potential pitfalls -- and whether the company can get by without another stock offering. Teva Pharmaceutical Industries (NYSE: TEVA), meanwhile, faces heavy debt and a challenging market that have cut its market cap in half. So is either a buy at current prices? 

A full transcript follows the video.

Continue reading

Source: Fool.com